Vision Science companies are investing in new ophthalmic products, diagnostic tools, platforms, and clinical technologies. But many teams still face the same challenge: moving from ideas, prototypes, and internal innovation efforts into scalable, validated, and clinically useful products.
The 2025 Vision Innovation Benchmark Report helps Vision Science leaders understand where the industry is investing, where innovation gets stuck, and what teams should prioritize in 2026.
